[Evaluation of a programme to monitor drug therapy in type-2 diabetics].
OBJECTIVE
To evaluate the results of pharmaceutical intervention in a programme to monitor the drug therapy of type-2 diabetics; and to assess the improvement of the indicators, glycosylated haemoglobin, basal glycaemia, lipid profile, albumin/creatinine, blood pressure, BMI, medication-related problems and adherence.


METHODS
Randomised clinical trial.


METHODS
14 local pharmacies in the province of Pontevedra (Galicia), Spain.


METHODS
126 type-2 diabetics, over 18 years old and who joined voluntarily a monitoring programme, distributed 50-50 into intervention and control groups.


METHODS
The main variable was HbA1c. Other variables were: clinical indicators of metabolic control (mean basal glycaemia, lipid profile), blood pressure, BMI, medication-related problems, understanding of the illness and its complications, adherence to medical treatment and to changes in life-style, and incidence of complications.


METHODS
Introduction and randomisation of patients. Recording of the initial status of the research variables, study and assessment stage, pharmaceutical interventions to detect and resolve any passing medication-related problems and educational activities. Referral to family doctor if his/her intervention required. Follow-up lasted 12 months with monthly scheduled visits and on-demand visits, after which the variables were assessed once more. The stages of study, evaluation, intervention and education did not occur in the control group.


CONCLUSIONS
The study will enable the role of the chemist in achieving the objectives of controlling type-2 diabetes patients to be achieved through educational intervention and assistance in drug therapy monitoring.
Fornos Pérez
J A
JA
Farmacéutico Comunitario en Cangas, Pontevedra, Spain.
Guerra García
M M
MM
Andrés Rodríguez
N F
NF
Egea Ibernón
B
B
D001786:Blood Glucose / Q000032:analysis; D016009:Chi-Square Distribution; D003627:Data Interpretation, Statistical; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008019:Life Style; D008297:Male; D010349:Patient Compliance; D010353:Patient Education as Topic; D013030:Spain; D013997:Time Factors
D001786:Blood Glucose; D006442:Glycated Hemoglobin